Sage Mountain Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Sage Mountain Advisors's PFE Position: Q1 2026 in Review
Sage Mountain Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 25,944 shares — an estimated $646K sold.
Sage Mountain Advisors first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $1.03M in Q1 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sage Mountain Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Sage Mountain Advisors sold 25,944 Pfizer shares in Q1 2026, an estimated $646K.
- Sage Mountain Advisors first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
- Sage Mountain Advisors's Pfizer position peaked at $1.03M in Q1 2023.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.